The Effectiveness of Dialectical Behavior Therapy on Rumination and Cognitive Avoidance in Teachers (NCT07650617) | Clinical Trial Compass
CompletedNot Applicable
The Effectiveness of Dialectical Behavior Therapy on Rumination and Cognitive Avoidance in Teachers
Iran34 participantsStarted 2024-09-15
Plain-language summary
This randomized controlled trial evaluated the effectiveness of Dialectical Behavior Therapy (DBT) skills training in reducing rumination and cognitive avoidance among middle-school teachers in Isfahan, Iran. Teachers often experience occupational stress that may contribute to maladaptive cognitive and emotional responses. DBT is a skills-based psychological intervention that aims to improve emotional regulation, mindfulness, distress tolerance, and interpersonal effectiveness.
Thirty-four eligible teachers were randomly assigned to either a DBT intervention group or a control group. Participants in the intervention group attended ten group sessions, while the control group received no intervention during the study period. Levels of rumination and cognitive avoidance were assessed at baseline, post-intervention, and two-month follow-up using standardized questionnaires.
The study aimed to determine whether DBT skills training could reduce maladaptive cognitive processes and promote psychological well-being among teachers.
Who can participate
Age range
35 Years – 52 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Female middle-school teachers from districts 4 and 5 of Isfahan, Iran.
* Age between 35 and 52 years.
* Willingness to participate and provide written informed consent.
* Ability to attend the intervention sessions and complete study assessments.
Exclusion Criteria:
* Absence from more than two intervention sessions.
* Withdrawal of consent at any stage of the study.
* Failure to complete post-intervention or follow-up assessments.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial used Dialectical Behavior Therapy specifically with teachers who struggle with rumination and cognitive avoidance — do you think DBT would be a good fit for my situation, even if I'm not a teacher?
2Since this study has already been completed, would you be able to help me find out what the results showed about whether DBT actually reduced rumination and cognitive avoidance in participants?
3This trial focused on two specific things — rumination and cognitive avoidance — but I'm dealing with other symptoms too. Would DBT still be worth considering for me, or is there a different therapy that targets a broader range of what I'm experiencing?
4Since this was a non-drug, behavioral therapy trial with no listed phase, what does that mean for how confident we can be in the safety and effectiveness of this approach compared to other established treatments?
5Are there standard, already-proven treatments for rumination or cognitive avoidance that I should try first before looking into approaches tested in studies like this one?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Cognitive Avoidance
Timeframe: Baseline, post-intervention (5 weeks), and 2-month follow-up.
2
Rumination
Timeframe: Baseline, post-intervention (5 weeks), and 2-month follow-up.